TG Therapeutics Inc. Stock
Price
Target price
€26.06
€26.06
-0.700%
-0.185
-0.700%
€51.29
23.12.25 / Tradegate
WKN: A1JXW7 / Symbol: TGTX / Name: TG Therapeutics / Stock / Biotechnology & Medical Research / Small Cap /
Please give a prediction to see the opinions of the community
sharewise uses Wisdom of crowds to gather information regarding a security. Wisdom of crowds works best if you do not see the predictions of others before giving your estimate. Please click one button to see how the community sees this security.
Your prediction
TG Therapeutics Inc. Stock
The price for the TG Therapeutics Inc. stock decreased slightly today. Compared to yesterday there is a change of -€0.185 (-0.700%).
With 6 Buy predictions and only 1 Sell predictions the community sentiment for the stock is positive.
As a result the target price of 51 € shows a very positive potential of 95.7% compared to the current price of 26.06 € for TG Therapeutics Inc..
Criterium "Worthwhile Investment for the next years" is seen as the biggest plus for TG Therapeutics Inc. stock. Negative votes have not been in the majority for any criteria for this stock
Pros and Cons of TG Therapeutics Inc. in the next few years
Pros
?
G***** c******* t* c**********
?
W********* I********* f** t** n*** y****
?
M***** P*******
Cons
?
B****
?
C******** o* t** e**********
?
S********** s********
Tell us your opinion to access the 'Wisdom of the Crowds'
Performance of TG Therapeutics Inc. vs. its peers
| Security | Change(%) | 1w | 1m | 1y | YTD | 3y | 5y |
|---|---|---|---|---|---|---|---|
| TG Therapeutics Inc. | -0.700% | 2.076% | -8.610% | -15.976% | -15.335% | 231.341% | -41.366% |
| Ardelyx Inc. | -1.890% | 1.694% | -0.364% | 11.858% | -0.826% | 131.663% | -14.721% |
| Krystal Biotech | 0.850% | 7.982% | 14.659% | 39.043% | 41.327% | 190.676% | - |
| Evolus Inc | -2.480% | 0.855% | -0.840% | -42.157% | -43.810% | -10.606% | 81.204% |
Comments
TG Therapeutics (NASDAQ:TGTX) was upgraded by analysts at Wall Street Zen from a "hold" rating to a "buy" rating.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (NASDAQ:TGTX) had its price target raised by analysts at JPMorgan Chase & Co. from $46.00 to $49.00. They now have an "overweight" rating on the stock.
Show more
Ratings data for TGTX provided by MarketBeat
TG Therapeutics (NASDAQ:TGTX) is now covered by analysts at HC Wainwright. They set a "buy" rating and a $60.00 price target on the stock.
Show more
Ratings data for TGTX provided by MarketBeat